<DOC>
	<DOC>NCT03082118</DOC>
	<brief_summary>Single arm study of the Vesair Balloon in postmenopausal women.</brief_summary>
	<brief_title>Vesair Continued Access Trial</brief_title>
	<detailed_description>All women enrolled will be treated with the vesair balloon and followed for a maximum of 3 years, with balloon replacement annually.</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence, Stress</mesh_term>
	<criteria>Postmenopausal women with SUI or stress predominant mixed incontinence Maximum score on IQOL of 60 Positive cough test for leakage Willing to undergo procedures Free from infection Have previously tried (and failed) noninvasive treatment for SUI SUI due to SUI Urgepredominant mixed incontinence Incontinence of neurogenic etiology 2 or more UTIs in past year and 1 in past 3 months Surgery for SUI in the past 6 months taking medication that can be used to treat SUI taking medication that affects urinary symptoms for less than 3 months undergoing biofeedback Grade 3 or worse cystocele last menstrual period within 12 months oral progesterone or estrogen in the past 12 months BMI &gt; 40 involuntary detrusor contractions or discomfort during bladder filling previous stage III or worse cancer previous cancer of the urinary tract previous symptoms for early stage cancer in the past 2 years anticoagulation therapy other than aspirin history of prosthetic heart valve neurological or connective tissue condition or disease affecting bladder function known allergy to device components</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>